Get started
Author

Helena Gioacchini

Observed name: H. Gioacchini
ORCID: 0009-0004-4099-3243
Observed ORCID: 0009-0004-4099-3243
OpenAlex ID: A5010151920
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art
2023 · Federico Diotallevi, Helena Gioacchini, et al. · International Journal of Molecular Sciences · 106
PDF
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa
2023 · Elisa Molinelli, Helena Gioacchini, et al. · International Journal of Molecular Sciences · 38
PDF
Bullous Pemphygoid and Novel Therapeutic Approaches
2022 · Giovanni Marco D’Agostino, Giulio Rizzetto, et al. · Biomedicines · 20
PDF
Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review
2024 · Elisa Molinelli, Helena Gioacchini, et al. · Dermatology and Therapy · 17
InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study
2023 · Federico Diotallevi, Giulia Matacchione, et al. · Dermatology and Therapy · 9
PDF
A case of pembrolizumab-induced bullous pemphigoid treated with dupilumab
2025 · Agnese Rossi, Donatella Brancorsini, et al. · Skin Health and Disease · 8
Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness
2024 · Andrea Marani, Helena Gioacchini, et al. · Toxins · 6
PDF
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study
2025 · Francesca Barei, Stefano Macchi, et al. · Clinical and Experimental Dermatology · 5
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study—IL PSO (Italian Landscape PSOriasis)
2025 · Helena Gioacchini, Agnese Rossi, et al. · Dermatology and Therapy · 5
PDF
Early dermoscopic and confocal features predict response to topical ruxolitinib in nonsegmental vitiligo: A prospective observational study
2025 · Helena Gioacchini, Giulia Veronesi, et al. · Journal of the American Academy of Dermatology · 4
PDF
Potential drug–drug interactions with mitogen-activated protein kinase (MEK) inhibitors used to treat melanoma
2023 · A. Marani, H. Gioacchini, et al. · Expert Opinion on Drug Metabolism & Toxicology · 4
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab—IL PSO (Italian Landscape Psoriasis)
2026 · Emanuele Trovato, Alessandra Cartocci, et al. · Dermatology and Therapy · 2
PDF
Advances in pharmacological treatment and management of hyperhidrosis
2026 · A. Rossi, H. Gioacchini, et al. · Expert Opinion on Pharmacotherapy · 2
Hidradenitis suppurativa associated with chromosomal abnormalities, genodermatoses and genetic disorders: a review
2025 · Elisa Molinelli, Helena Gioacchini, et al. · Clinical and Experimental Dermatology · 2
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study
2023 · Elisa Molinelli, Giovanni Marco D’Agostino, et al. · Journal of the European Academy of Dermatology and Venereology · 2
Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence
2025 · Francesca Barei, Paolo Calzari, et al. · Dermatitis · 1
Efficacy and Safety of Glycopyrronium Bromide 1% Cream in Axillary and Extra‐Axillary Primary Hyperhidrosis: A Real‐Life Two‐Center Experience on 68 Subjects
2025 · Helena Gioacchini, Andrea Marani, et al. · Dermatologic Therapy · 1
PDF
Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study
2024 · Giulio Rizzetto, Edoardo De Simoni, et al. · Life · 1
PDF
Explorative Correlation of Atopic Dermatitis Control Tool with Minimal Disease Activity Patient-reported Outcomes in Patients Treated with Upadacitinib: A Retrospective Real-world Study
2026 · Filomena Russo, Natale Schettini, et al. · Acta Dermato Venereologica
PDF
Current Challenges in Atopic Dermatitis: An Italian Delphi Consensus with a Special Focus on Moderate Disease
2026 · Antonio Costanzo, Anna Campanati, et al. · Dermatology and Therapy
PDF
Works count: 20
Citation count: 233
H-index: 6
I10-index: 4
Year
Topic
Type